Marker rhythms of circadian system function: a study of patients with metastatic colorectal cancer and good performance status

Cancer patients may exhibit normal or altered circadian rhythms in tumor and healthy tissues. Four rhythms known to reflect circadian clock function were studied in 18 patients with metastatic colorectal cancer and good performance status. Rest–activity was monitored by wrist actigraphy for 72 h before treatment, and its circadian rhythm was estimated by an autocorrelation coefficient at 24h and a dichotomy index that compared the activity level when in and out of bed. Blood samples (9–11 time points, 3–6 h apart) were drawn on day 1 and day 4 of the first course of chronochemotherapy (5-fluorouracil: 800 mg/m2/day; folinic acid: 300 mg/m2/day; oxaliplatin: 25 mg/m2/day). Group 24h rhythms were validated statistically for plasma concentrations of melatonin, 6-α-sulfatoxymelatonin, and cortisol and for lymphocyte counts. Significant individual 24h rhythms were displayed in melatonin by 15 patients, cortisol by seven patients, lymphocytes by five patients, and prominent circadian rhythms in activity were displayed by 10 patients; only one patient exhibited significant rhythms in all the variables. The results suggest the rhythms of melatonin, cortisol, lymphocytes, and rest/activity reflect different components of the circadian system, which may be altered differently during cancer processes. Such 24h rhythm alterations appeared to be independent of conventional clinical factors.

[1]  J Lellouch,et al.  Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  H. Kraemer,et al.  Diurnal cortisol rhythm as a predictor of breast cancer survival. , 2000, Journal of the National Cancer Institute.

[3]  U. Schibler,et al.  A Serum Shock Induces Circadian Gene Expression in Mammalian Tissue Culture Cells , 1998, Cell.

[4]  Steven H. Strogatz,et al.  Cellular Construction of a Circadian Clock: Period Determination in the Suprachiasmatic Nuclei , 1997, Cell.

[5]  F. Lévi,et al.  Persistent T lymphocyte rhythms despite suppressed circadian clock outputs in rats. , 1997, American journal of physiology. Regulatory, integrative and comparative physiology.

[6]  S. Kay,et al.  Independent photoreceptive circadian clocks throughout Drosophila. , 1997, Science.

[7]  F. Lévi,et al.  Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer , 1997, The Lancet.

[8]  Minoru Tanaka,et al.  Positional Cloning of the Mouse Circadian Clock Gene , 1997, Cell.

[9]  J. Krueger,et al.  Diurnal variation of TNFα in the rat brain , 1997 .

[10]  F. Lévi,et al.  Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: relationships with tumour marker antigens. , 1996, British Journal of Cancer.

[11]  F. Lévi,et al.  [Study of circadian rhythms of activity by actometry: preliminary results in 30 patients with metastatic colorectal cancer]. , 1996, Pathologie-biologie.

[12]  D. Kripke,et al.  The role of actigraphy in the evaluation of sleep disorders. , 1995, Sleep.

[13]  F. Lévi,et al.  Light-induced suppression of the rat circadian system. , 1995, The American journal of physiology.

[14]  F. Lévi,et al.  Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial. , 1994, Journal of the National Cancer Institute.

[15]  D. Mecke,et al.  Diminished Pineal Function Coincides with Disturbed Circadian Endocrine Rhythmicity in Untreated Primary Cancer Patients , 1994, Annals of the New York Academy of Sciences.

[16]  D. P. King,et al.  Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior. , 1994, Science.

[17]  J. Herbert,et al.  The Suprachiasmatic Nucleus. The Mind's Clock. , 1994 .

[18]  S. Sandberg,et al.  Circadian variation in serum cortisol and circulating neutrophils are markers for circadian variation of bone marrow proliferation in cancer patients , 1993, European journal of haematology.

[19]  A. Reinberg,et al.  A chronopharmacologic phase II clinical trial with 5‐fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer , 1992, Cancer.

[20]  G. Chazot,et al.  Direct radioimmunoassay of 6-sulfatoxymelatonin in plasma with use of an iodinated tracer. , 1991, Clinical chemistry.

[21]  J. Tobias,et al.  Half-body irradiation in multiple myeloma. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  H. Bartsch,et al.  Depression of serum melatonin in patients with primary breast cancer is not due to an increased peripheral metabolism , 1991, Cancer.

[23]  A. Reinberg,et al.  Chemotherapy of advanced ovarian cancer with 4'-O-tetrahydropyranyl doxorubicin and cisplatin: a randomized phase II trial with an evaluation of circadian timing and dose-intensity. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  F. Davis,et al.  Transplanted suprachiasmatic nucleus determines circadian period. , 1990, Science.

[25]  Harold B. Dowse,et al.  The search for hidden periodicities in biological time series revisited , 1989 .

[26]  H. Bartsch,et al.  Stage‐dependent depression of melatonin in patients with primary breast cancer. Correlation with prolactin, thyroid stimulating hormone, and steroid receptors , 1989, Cancer.

[27]  T. Kral,et al.  The immune-hypothalamic-pituitary-adrenal axis. , 1989, Endocrine reviews.

[28]  W. Hrushesky.  Circadian timing of cancer chemotherapy. , 1985, Science.

[29]  S. Flüchter,et al.  Evidence for Modulation of Melatonin Secretion in Men With Benign and Malignant Tumors of the Prostate: Relationship With the Pituitary Hormones , 1985, Journal of pineal research.

[30]  E. Haus,et al.  Chronobiology in hematology and immunology. , 1983, The American journal of anatomy.

[31]  P. Cowen,et al.  Direct radioimmunoassay for melatonin in plasma. , 1983, Clinical chemistry.

[32]  M. Lippman,et al.  Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer. , 1982, Science.

[33]  J. Sulon,et al.  Adrenal circadian system in young and elderly human subjects: a comparative study. , 1982, The Journal of endocrinology.

[34]  F Halberg,et al.  Methods for cosinor-rhythmometry. , 1979, Chronobiologia.

[35]  I. Zucker,et al.  Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[36]  B. Lemmer,et al.  Physiology and Pharmacology of Biological Rhythms , 1997, Handbook of Experimental Pharmacology.

[37]  F. Lévi.  Chronopharmacology of Anticancer Agents , 1997 .

[38]  G. Atkinson,et al.  The difference between activity when in bed and out of bed. III. Nurses on night work. , 1996, Chronobiology international.

[39]  G. Atkinson,et al.  The difference between activity when in bed and out of bed. I. Healthy subjects and selected patients. , 1996, Chronobiology international.

[40]  Manuel Benavides Orgaz.  Cancer avance de l'ovaire : approche chronobiologique comme nouvelle strategie du traitement et de la surveillance clinique et biologique , 1991 .

[41]  A. Reinberg,et al.  Interindividual differences in the circadian hematologic time structure of cancer patients. , 1986, Chronobiology international.

[42]  C A Czeisler,et al.  Mathematical model of the human circadian system with two interacting oscillators. , 1982, The American journal of physiology.